{"id":"https://openalex.org/W4200511560","doi":"https://doi.org/10.1038/s41416-021-01676-4","title":"No evidence of disease versus residual disease in long-term responders to first-line HER2-targeted therapy for metastatic breast cancer","display_name":"No evidence of disease versus residual disease in long-term responders to first-line HER2-targeted therapy for metastatic breast cancer","publication_year":2021,"publication_date":"2021-12-20","ids":{"openalex":"https://openalex.org/W4200511560","doi":"https://doi.org/10.1038/s41416-021-01676-4","pmid":"https://pubmed.ncbi.nlm.nih.gov/34931041","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8927598"},"language":"en","primary_location":{"id":"doi:10.1038/s41416-021-01676-4","doi":"https://doi.org/10.1038/s41416-021-01676-4","is_oa":false,"landing_page_url":"https://doi.org/10.1038/s41416-021-01676-4","pdf_url":null,"source":{"id":"https://openalex.org/S62966998","display_name":"British Journal of Cancer","issn_l":"0007-0920","issn":["0007-0920","1532-1827"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Cancer","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8927598/","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5065153048","display_name":"Zachary William Neil Veitch","orcid":"https://orcid.org/0000-0002-3223-5045","observed_orcids":["https://orcid.org/0000-0002-3223-5045"]},"institutions":[{"id":"https://openalex.org/I1297363086","display_name":"St. Michael's Hospital","ror":"https://ror.org/04skqfp25","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1297363086","https://openalex.org/I4399598460"]},{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":true,"raw_author_name":"Zachary Veitch","raw_affiliation_strings":["Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada. veitchz@rvh.on.ca","Department of Medical Oncology and Hematology, St Michael's Hospital, Toronto, ON, Canada. veitchz@rvh.on.ca","Department of Medical Oncology and Hematology, St Michael's Hospital, Toronto, ON, Canada"],"raw_orcid":"https://orcid.org/0000-0002-3223-5045","affiliations":[{"raw_affiliation_string":"Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada. veitchz@rvh.on.ca","institution_ids":["https://openalex.org/I2802654988"]},{"raw_affiliation_string":"Department of Medical Oncology and Hematology, St Michael's Hospital, Toronto, ON, Canada. veitchz@rvh.on.ca","institution_ids":["https://openalex.org/I1297363086"]},{"raw_affiliation_string":"Department of Medical Oncology and Hematology, St Michael's Hospital, Toronto, ON, Canada","institution_ids":["https://openalex.org/I1297363086"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081823264","display_name":"Domen Ribnikar","orcid":"https://orcid.org/0000-0001-5146-4524","observed_orcids":["https://orcid.org/0000-0001-5146-4524"]},"institutions":[{"id":"https://openalex.org/I3019592416","display_name":"Institute of Oncology Ljubljana","ror":"https://ror.org/00y5zsg21","country_code":"SI","type":"facility","lineage":["https://openalex.org/I3019592416"]}],"countries":["SI"],"is_corresponding":false,"raw_author_name":"Domen Ribnikar","raw_affiliation_strings":["Medical Oncology Department, Institute of Oncology Ljubljana, Ljubljana, Slovenia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Department, Institute of Oncology Ljubljana, Ljubljana, Slovenia","institution_ids":["https://openalex.org/I3019592416"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110060655","display_name":"Derek G. Tilley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I126859394","display_name":"Alberta Health Services","ror":"https://ror.org/02nt5es71","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I126859394"]},{"id":"https://openalex.org/I4405274285","display_name":"Cancer Care Alberta","ror":"https://ror.org/01e67n130","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I4405274285"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Derek Tilley","raw_affiliation_strings":["Cancer Care Alberta, Alberta Health Services, Calgary, AB, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Care Alberta, Alberta Health Services, Calgary, AB, Canada","institution_ids":["https://openalex.org/I126859394","https://openalex.org/I4405274285"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023283384","display_name":"Patricia A. Tang","orcid":"https://orcid.org/0000-0003-1497-8539","observed_orcids":["https://orcid.org/0000-0003-1497-8539"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Patricia A. Tang","raw_affiliation_strings":["Department of Medical Oncology, Tom Baker Cancer Centre, Calgary, AB, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Tom Baker Cancer Centre, Calgary, AB, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021077843","display_name":"Karen Marie King","orcid":"https://orcid.org/0000-0002-0755-7376","observed_orcids":["https://orcid.org/0000-0002-0755-7376"]},"institutions":[{"id":"https://openalex.org/I154425047","display_name":"University of Alberta","ror":"https://ror.org/0160cpw27","country_code":"CA","type":"education","lineage":["https://openalex.org/I154425047"]},{"id":"https://openalex.org/I4405258411","display_name":"Cross Cancer Institute","ror":"https://ror.org/00m3k3802","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I4405258411"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Karen King","raw_affiliation_strings":["Department of Medical Oncology, Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada","institution_ids":["https://openalex.org/I154425047","https://openalex.org/I4405258411"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041145711","display_name":"Philippe Lucien Bedard","orcid":"https://orcid.org/0000-0002-6771-2999","observed_orcids":["https://orcid.org/0000-0002-6771-2999"]},"institutions":[{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Philippe L. Bedard","raw_affiliation_strings":["Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada","institution_ids":["https://openalex.org/I2802654988"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091875778","display_name":"Sasha Lupichuk","orcid":"https://orcid.org/0000-0001-9545-0802","observed_orcids":["https://orcid.org/0000-0001-9545-0802"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sasha Lupichuk","raw_affiliation_strings":["Department of Medical Oncology, Tom Baker Cancer Centre, Calgary, AB, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Tom Baker Cancer Centre, Calgary, AB, Canada","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5060911347","display_name":"David W. Cescon","orcid":"https://orcid.org/0000-0002-1080-0998","observed_orcids":["https://orcid.org/0000-0002-1080-0998"]},"institutions":[{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"David W. Cescon","raw_affiliation_strings":["Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada"],"raw_orcid":"https://orcid.org/0000-0002-1080-0998","affiliations":[{"raw_affiliation_string":"Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada","institution_ids":["https://openalex.org/I2802654988"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5065153048"],"corresponding_institution_ids":["https://openalex.org/I1297363086","https://openalex.org/I2802654988"],"apc_list":{"value":4480,"currency":"USD","value_usd":4480},"apc_paid":null,"fwci":0.5991,"has_fulltext":false,"cited_by_count":13,"citation_normalized_percentile":{"value":0.65674128,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"126","issue":"6","first_page":"881","last_page":"888"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.9039999842643738},{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.9760000109672546},{"id":"https://openalex.org/keywords/no-evidence-of-disease","display_name":"no evidence of disease","score":0.8399999737739563},{"id":"https://openalex.org/keywords/residual-disease","display_name":"residual disease","score":0.9919999837875366},{"id":"https://openalex.org/keywords/long-term-response","display_name":"long-term response","score":0.7020000219345093},{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":0.8769999742507935},{"id":"https://openalex.org/keywords/pertuzumab","display_name":"pertuzumab","score":0.9480000138282776},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.7730000019073486},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.7620000243186951},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9980000257492065},{"id":"https://openalex.org/keywords/premenopausal-status","display_name":"premenopausal status","score":0.9649999737739563},{"id":"https://openalex.org/keywords/palliative-radiotherapy","display_name":"palliative radiotherapy","score":0.9679999947547913}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.882522702217102},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.757897138595581},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.6523196697235107},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.6364365220069885},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6279892921447754},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.5608394742012024},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5309625864028931},{"id":"https://openalex.org/C2777511904","wikidata":"https://www.wikidata.org/wiki/Q425227","display_name":"Taxane","level":4,"score":0.48826122283935547},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.473112553358078},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.43082913756370544},{"id":"https://openalex.org/C2777329042","wikidata":"https://www.wikidata.org/wiki/Q420323","display_name":"Lapatinib","level":5,"score":0.42647111415863037},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4185980558395386},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4119226932525635},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3501783013343811},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.1649700105190277}],"mesh":[{"descriptor_ui":"D000068878","descriptor_name":"Trastuzumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018572","descriptor_name":"Disease-Free Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018719","descriptor_name":"Erb-b2 Receptor Tyrosine Kinases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1038/s41416-021-01676-4","doi":"https://doi.org/10.1038/s41416-021-01676-4","is_oa":false,"landing_page_url":"https://doi.org/10.1038/s41416-021-01676-4","pdf_url":null,"source":{"id":"https://openalex.org/S62966998","display_name":"British Journal of Cancer","issn_l":"0007-0920","issn":["0007-0920","1532-1827"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Cancer","raw_type":"journal-article"},{"id":"pmid:34931041","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34931041","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of cancer","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:8927598","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8927598/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Cancer","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:8927598","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8927598/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Cancer","raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":38,"referenced_works":["https://openalex.org/W1530219086","https://openalex.org/W1971209307","https://openalex.org/W1996778928","https://openalex.org/W2009402447","https://openalex.org/W2011922596","https://openalex.org/W2022774588","https://openalex.org/W2025106994","https://openalex.org/W2030715002","https://openalex.org/W2113670583","https://openalex.org/W2137228442","https://openalex.org/W2141929347","https://openalex.org/W2159967578","https://openalex.org/W2217460114","https://openalex.org/W2258141165","https://openalex.org/W2329462060","https://openalex.org/W2514009911","https://openalex.org/W2588881638","https://openalex.org/W2609953159","https://openalex.org/W2734334343","https://openalex.org/W2754658727","https://openalex.org/W2756047476","https://openalex.org/W2763299180","https://openalex.org/W2785610956","https://openalex.org/W2888034547","https://openalex.org/W2914643394","https://openalex.org/W2942790586","https://openalex.org/W2947783920","https://openalex.org/W2953684910","https://openalex.org/W2995808512","https://openalex.org/W2996401310","https://openalex.org/W2996630100","https://openalex.org/W3010197652","https://openalex.org/W3011438376","https://openalex.org/W3012544261","https://openalex.org/W3043096450","https://openalex.org/W3088588360","https://openalex.org/W3109124091","https://openalex.org/W3203425221"],"related_works":["https://openalex.org/W2946868463","https://openalex.org/W4396587599","https://openalex.org/W2888034547","https://openalex.org/W2622511079","https://openalex.org/W7135120880","https://openalex.org/W2971842286","https://openalex.org/W4296295642","https://openalex.org/W4415815608","https://openalex.org/W2767229364","https://openalex.org/W7113653385"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2021-12-31T00:00:00"}